Conover C A, Hintz R L, Johnson B F
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.
J Cell Physiol. 1995 Jun;163(3):615-22. doi: 10.1002/jcp.1041630323.
Glucocorticoids act synergistically with insulin-like growth factor I (IGF-I) to stimulate DNA synthesis and replication of cultured human fibroblasts. In the present study, we further define glucocorticoid and IGF-I interactive effects on human fibroblast metabolism and growth. IGF-I stimulated dose-dependent increases in early metabolic events. Half-maximal effectiveness was seen at 5-8 ng/ml IGF-I, with mean maximal responses of 1.5-, 2-, and 6-fold for [3H]2-deoxyglucose uptake, [14C]glucose incorporation, and [14C]aminoisobutyric acid (AIB) uptake, respectively. A 48-hour preincubation with 10(-7) M dexamethasone markedly enhanced both the sensitivity and maximal effectiveness of IGF-I stimulation of AIB uptake. In contrast, dexamethasone had no effect on IGF-I-stimulated glucose uptake and utilization. Maximum specific binding of [125I]IGF-I to fibroblast monolayers was identical in ethanol control and glucocorticoid-treated cells, with 50% displacement at approximately 5 ng/ml IGF-I. In addition to its synergism with IGF-I, preincubation with dexamethasone augmented insulin and epidermal growth factor (EGF) stimulation of [3H]thymidine incorporation; dexamethasone had no effect on platelet-derived growth factor or fibroblast growth factor action. Two-dimensional gel electrophoresis identified two specific glucocorticoid-induced proteins in human fibroblast cell extracts with molecular weights of 45K and 53K and pIs of 6.8 and 6.3, respectively. These data indicate that IGF-I receptor-mediated actions in human fibroblasts are differentially modulated by glucocorticoids. Glucocorticoids are synergistic with IGF-I in stimulating mitogenesis and amino acid uptake, without having any apparent effect on IGF-I-stimulating glucose metabolism. Glucocorticoid enhancement of growth factor bioactivity may involve modulation of a regulatory event in the mitogenic signaling pathway subsequent to cell surface receptor activation.
糖皮质激素与胰岛素样生长因子I(IGF-I)协同作用,刺激培养的人成纤维细胞的DNA合成和复制。在本研究中,我们进一步确定了糖皮质激素和IGF-I对人成纤维细胞代谢和生长的交互作用。IGF-I刺激早期代谢事件呈剂量依赖性增加。在5-8 ng/ml IGF-I时可见半数最大效应,[3H]2-脱氧葡萄糖摄取、[14C]葡萄糖掺入和[14C]氨基异丁酸(AIB)摄取的平均最大反应分别为1.5倍、2倍和6倍。用10(-7) M地塞米松预孵育48小时显著增强了IGF-I刺激AIB摄取的敏感性和最大效应。相比之下,地塞米松对IGF-I刺激的葡萄糖摄取和利用没有影响。[125I]IGF-I与成纤维细胞单层的最大特异性结合在乙醇对照细胞和糖皮质激素处理的细胞中相同,在约5 ng/ml IGF-I时50%被置换。除了与IGF-I协同作用外,用地塞米松预孵育增强了胰岛素和表皮生长因子(EGF)对[3H]胸苷掺入的刺激作用;地塞米松对血小板衍生生长因子或成纤维细胞生长因子的作用没有影响。二维凝胶电泳在人成纤维细胞提取物中鉴定出两种糖皮质激素诱导的特异性蛋白质,分子量分别为45K和53K,等电点分别为6.8和6.3。这些数据表明,糖皮质激素对人成纤维细胞中IGF-I受体介导的作用有不同的调节。糖皮质激素与IGF-I协同刺激有丝分裂和氨基酸摄取,而对IGF-I刺激的葡萄糖代谢没有明显影响。糖皮质激素增强生长因子生物活性可能涉及在细胞表面受体激活后对有丝分裂信号通路中调节事件的调节。